Eniko Papp

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study

Tanya Siddiqi, David G. Maloney, Saad S. Kenderian et al. · The Lancet · 2023 · 174 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Transcend Cll 004 +9

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells

Iris van ’t Erve, Jamie E. Medina, Alessandro Leal et al. · Clinical Cancer Research · 2022 · 37 citations · Full text

Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia

Tatiana Perova, Ildiko Grandal, Lauryl M. J. Nutter et al. · Science Translational Medicine · 2014 · 34 citations

Pre-b Cell Receptor, Hematological Malignancy, Therapeutic Potential +15

B cell acute lymphoblastic leukemia cells mediate RANK-RANKL–dependent bone destruction

Sujeetha A. Rajakumar, Eniko Papp, Kathy K. Lee et al. · Science Translational Medicine · 2020 · 34 citations

Lisocabtagene Maraleucel (liso-cel) Combined with Ibrutinib (ibr) for Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Primary Results from the Open-Label, Phase 1/2 Transcend CLL 004 Study

William G. Wierda, Kathleen Dorritie, Jordan Gauthier et al. · Blood · 2024 · 16 citations · Full text